We are live on ! Find out more
GF

Gates Foundation Portfolio holdings

AUM $43.5M
1-Year Est. Return 14.19%
This Fund
S&P 500
This Quarter Est. Return
+44.03%
1 Year Est. Return
+14.19%
3 Year Est. Return
-58.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$438M
AUM Growth
–
Cap. Flow
+$454M
Cap. Flow %
103.72%
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CVAC
CureVac
CVAC
+$240M
2
BNTX icon
BioNTech
BNTX
+$102M
3
VIR icon
Vir Biotechnology
VIR
+$90.3M
4
BCEL
Atreca, Inc. Class A Common Stock
BCEL
+$20.9M
5
AMRS
Amyris Inc.
AMRS
+$935K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.59%
2 Materials 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVAC
1
DELISTED
CureVac
CVAC
$254M 58.02%
+3,134,780
New +$240M
BNTX icon
2
BioNTech
BNTX
$22.6B
$85M 19.42%
+1,038,674
New +$102M
VIR icon
3
Vir Biotechnology
VIR
$1.47B
$74M 16.9%
+2,777,777
New +$90.3M
BCEL
4
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$23M 5.25%
+1,396,644
New +$20.9M
AMRS
5
DELISTED
Amyris Inc.
AMRS
$1.8M 0.41%
+292,398
New +$935K

Similar funds

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
SCMC
Serent Capital Management Company San Francisco, California $44.9M AUM 20.57% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
AS
AM Squared Hong Kong $45.2M AUM 4.27% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

Gates Foundation's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Gates Foundation, which disclosed 5 positions worth $438M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is CureVac: 3,134,780 shares worth $254M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, followed by Materials.

  • Gates Foundation's largest Q4 2020 buy was CureVac: 3,134,780 shares worth $254M.
  • Gates Foundation's ten largest holdings make up 100% of its $438M portfolio in Q4 2020.
  • Gates Foundation disclosed 5 positions in Q4 2020, its first 13F filing on record.

Based on Gates Foundation's 13F filing for Q4 2020, filed 16 Feb 2021.